Brief: Dawnrays Pharmaceutical Says Anti-Infective Drug Of Suzhou Dawnrays Obtained Approval
15/07/2019 15:23
July 15 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
2348.HK :
* ANTI-INFECTIVE DRUG OF SUZHOU DAWNRAYS OBTAINED APPROVAL
FOR
REGISTRATION BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION
RECENTLY
Source text for Eikon: ID:nHKS45B9sb
Further company coverage: 2348.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO